Antibody directed against pro-gastrin releasing peptide, and use thereof
AssigneeAdvanced Life Science Institute, Inc.
InventorsKatsumi Aoyagi, Yukiji Izawa
Life of this patent
Estimating the term…
Loading patent…
AssigneeAdvanced Life Science Institute, Inc.
InventorsKatsumi Aoyagi, Yukiji Izawa
Estimating the term…
Disclosed is a novel high-sensitive ProGRP measurement method, which is free from problems such as the fluctuations in measurement values and the operational constraints (e.g., the constraints on the handling of a sample). Specifically disclosed is a method for the measurement of a gastrin-releasing peptide precursor and/or a digested product thereof using at least two different antibodies each of which can recognize an epitope represented by the amino acid sequence consisting of amino acid 47 to amino acid 68 of the amino acid sequence set forth in SEQ ID NO:1. The method can detect a ProGRP or a digested product thereof in a refrigerated sample within a shorter period, by using the sample in a smaller amount, and with a higher degree of detective sensitivity, compared with the conventional methods.
A method for measuring a gastrin-releasing peptide precursor and/or a digested product thereof, using two or more different antibodies which are capable of recognizing an epitope represented by an amino acid sequence consisting of amino acid 47 to amino acid 68 of the amino acid sequence set forth in SEQ ID NO:
A monoclonal antibody capable of recognizing an epitope represented by an amino acid sequence consisting of amino acid 47 to amino acid 68 of the amino acid sequence set forth in SEQ ID NO:
Hybridoma GCY9 deposited under Accession No. FERM P-21308.
Hybridoma GCY17 deposited under Accession No. FERM P-21309.
Dependencies are inferred from the claim text.